Author

Neel Vaidya

Observed names: N Vaidya, N. Vaidya, Vaidya, Neel

Observed institutions: United States Department of Veterans Affairs, Veterans Health Administration, STATinMED (United States), Takeda (United States), VA Greater Los Angeles Healthcare System, University of Colorado Anschutz, University of Colorado Denver

ORCID: 0000-0002-5697-5881

Observed ORCID: 0000-0002-5697-5881

OpenAlex ID: A5041258466

A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

2018 · Maria J. Redondo, Susan Geyer, et al. · Diabetes Care · 174

Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States

2020 · Camilo Obando, Zhijie Ding, et al. · Advances in Therapy · 29

PDF

Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of U.S. Claims Data

2019 · Tara A. Nazareth, Furaha Kariburyo, et al. · Journal of Managed Care & Specialty Pharmacy · 16

PDF

Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population

2018 · Seina Lee, Lin Xie, et al. · Journal of Medical Economics · 13

PDF

Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population

2018 · Seina Lee, Lin Xie, et al. · Journal of Managed Care & Specialty Pharmacy · 11

PDF

Hypoglycaemia and treatment patterns among insulin‐treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real‐world setting

2019 · Fang L. Zhou, Charlie Nicholls, et al. · Endocrinology Diabetes & Metabolism · 8

PDF

Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiating basal insulin

2017 · Fang Liz Zhou, Lin Xie, et al. · Diabetes Obesity and Metabolism · 7

PDF

Characterization of the real-world first line (1L) use of single dose tremelimumab regular interval durvalumab (STRIDE), for treatment of unresectable hepatocellular carcinoma (uHCC), using two electronic medical record (EMR) databases.

2025 · Aparna Chauhan, Mufiza Farid-Kapadia, et al. · Journal of Clinical Oncology · 2

Impact of Assisted Reproductive Therapy (Art) On Infant Health and Health Care Cost Outcomes

2014 · D.C. Tabano, A. Schroeder, et al. · Value in Health · 2

Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021

2025 · Janna Manjelievskaia, Viral N. Shah, et al. · Diabetic Medicine · 1

PDF

CO89 Reductions in Concomitant Medication Use and HbA1c Impact Following Initiation of an Advanced Hybrid Closed-Loop System (AHCL) Versus Multiple Daily Injection (MDI) Therapy in People With Type 2 Diabetes (T2D)

2024 · BV Patel, J Manjelievskaia, et al. · Value in Health · 1

PDF

Mo1779 - Evaluate the Treatment Patterns and Healthcare Utilizations for Biologic Therapies for Crohn's Disease

2018 · Camilo Obando, Lin Xie, et al. · Gastroenterology · 1

A Cost-Effectiveness analysis of Pre-Exposure Prophylaxis for Hiv: a Us Payer Perspective

2015 · N. Vaidya, J.D. Campbell · Value in Health · 1

A Health Technology Assessment of a Proposed Biosimilar for the Treatment of Chemotherapy Induced Febrile Neutropenia: A United States Payer Perspective

2014 · N. Vaidya, L. Cosler · Value in Health · 1

Real-World Treatment Utilization and Patterns of Adjuvant Olaparib for Early-Stage Breast Cancer: Insights from the Komodo Research Database

2026 · Felipe Batalini, Qixin Li, et al. · Current Oncology

Ee475 Out-of-pocket Cost Burden Among Patients Diagnosed With Breast Cancer and Mental Health Comorbidities: a Cross-sectional Study Using Medical Expenditure Panel Survey (meps) Data

2026 · Neel Vaidya, Ali Bonakdar, et al. · Value in Health

794P A fruquintinib expanded access program (EAP) to provide treatment for patients with metastatic colorectal cancer (mCRC)

2025 · S. Kasper-Virchow, H. Karachiwala, et al. · Annals of Oncology

Patient characteristics and utilization patterns of olaparib in patients with early-stage breast cancer (eBC): Real-world insights using Komodo Healthcare Map (KHM).

2025 · Felipe Batalini, Qixin Li, et al. · Journal of Clinical Oncology

PDF

EE125 Evaluating the Impact of Hybrid Closed-Loop Systems (HCLS) on Healthcare Utilization and Costs Compared to Standard of Care Therapy Among Patients with Type 1 Diabetes New to Pump Therapy

2024 · J Manjelievskaia, N Vaidya, et al. · Value in Health

PDF

Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)

2024 · Marigdalia K. Ramirez-Fort, Casey K. Gilman, et al. · Frontiers in Medicine

PDF

Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1)

2024 · Ramirez-Fort, Marigdalia K, Gilman, Casey K, et al. · Zurich Open Repository and Archive (University of Zurich)

Mo1907 – Evaluation of Ustekinumab Treatment Patterns Among Crohn’s Disease Patients in Three Large US Commercial Claims Databases

2019 · Camilo Obando, Zhijie Ding, et al. · Gastroenterology

PDF

Mo1909 – Evaluation of Health Care Utilization, Hospitalization/Emergency Room Costs, and Other Medication Use Among Crohn’s Disease Patients Using Ustekinumab in Three Large United States Commercial Claims Databases

2019 · Camilo Obando, Zhijie Ding, et al. · Gastroenterology

PDF

Evaluating The Economic Burden And Health Care Utilization Of Bacterial Pneumonia In The US Department Of Defense Population

2017 · N Vaidya, Y Wang, et al. · Value in Health

PDF

Evaluating The Economic Burden and Health Care Utilization Of Breast Cancer in The Us Medicare Population

2016 · L Xie, N Vaidya, et al. · Value in Health

Works count: 28

Citation count: 267

H-index: 7

I10-index: 5